View Article

Abstract

Around the world, conjunctivitis is a prevalent ailment seen in ophthalmology clinics. Alarming indicators of more serious intraocular disorders, such as significant pain, impaired vision, and painful pupillary reaction, must be taken into consideration when managing suspected cases of conjunctivitis. Patients with unusual results and a chronic course should also have a comprehensive physical examination as well as a complete medical and ophthalmic history. Conjunctival involvement in a systemic disease may be detected by concurrent physical exam findings and pertinent history. Conjunctivitis caused by viruses is still the most common cause of the condition overall. Although it is less common, bacterial conjunctivitis is the second most common cause of infectious conjunctivitis. About 50% of people experience allergic conjunctivitis, which is characterized by itching, mucoid discharge, chemosis, and edema of the eyelids. When patients with conjunctival irritation and discharge use preservative-containing eye drops over an extended period of time, toxic conjunctivitis is likely the underlying cause. Timely diagnosis, adequate classification of the various etiologist, and suitable treatment are all important components of effective conjunctivitis care.

Keywords

Bacterial, viral, toxic, allergic, conjunctivitis, COVID-19, and coronavirus

Reference

  1. Shekhawat NS, Shtein RM, Blachley TS, Stein JD. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology 2017;124:1099–1107.
  2. Bedside diagnosis of the "Red Eye": a systematic review by Narayana S and McGee S. 2015;128:1220–1224.e1221. Am J Med.
  3. Woodland RM, Darougar S, Thaker U, Cornell L,  Siddique M, Wania J, et al. Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan. Trans Royal Soc Trop Med Hygiene 1992;86:317–320.
  4. Everitt H, Little P. How do GPs diagnose and manage acute infective conjunctivitis? A GP survey. Fam Pract 2002;19:658–660.
  5. Friedlaender MH. Ocular allergy. Curr Opin Allergy Cli Immunol 2011;11:477–48
  6. Bielory L, Frohman LP. Allergic and immunologic disorder of the eye. J Allergy Clin Immunol 1992;89:1–15.
  7. Rietveld RP, van Weert HC, ter Riet G, Bindels PJ. Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search. BM 2003;327:78
  8. Drew RJ, Cole TS, Newman W. How to use… eye swabs Arch Dis Child Educ Pract Ed 2015;100:155–161
  9. Wong VW, Lai TY, Chi SC, Lam DS. Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment. Cornea 2011;30:995–1002.
  10. Kam KY, Ong HS, Bunce C, Ogunbowale L, Verma S. Sensitivity and specificity of the Adeno Plus point-of-care system in detecting adenovirus in conjunctivitis patient at an ophthalmic emergency department: a diagnost accuracy study. Br J Ophthalmol 2015;99:1186–1189
  11. Newman H, Gooding C. Viral ocular manifestations: a broad overview. Rev Med Virol 2013;23:281–294.
  12. Singh G, Zhou X, Lee JY, Yousuf MA, Ramke M, Ismail AM, et al. Recombination of the epsilon determinant and corneal tropism: human adenovirus species D types 15, 29, 56, and 69. Virology 2015;485:452–459,
  13. Harley D, Harrower B, Lyon M, Dick A. A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Comm Dis Intell 2001;25:9–12
  14. Jackson WB, Low DE, Dattani D, Whitsitt PF, Leede MacDougall R. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Can J Ophthalmol 2002;37:228–237; discussion 237.
  15. Bremond-Gignac D, Mariani-Kurkdjian P, Beresniak A, El Fekih L, Bhagat Y, Pouliquen P, et al. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients. Pediatr Infect Dis J 2010;29:222–226.
  16. Puri LR, Shrestha GB, Shah DN, Chaudhary M, Thakur A. Ocular manifestations in herpes zoster ophthalmicus. Nepal J Ophthalmol 2011;3:165–171.
  17. Zhang L, Zhao N, Huang X, Jin X, Geng X, Chan TC, et al. Molecular epidemiology of acute hemorrhagic conjunctivitis caused by coxsackie a type 24 variant in China, 2004-2014. Sci Rep 2017;7:45202
  18. Serin S, Bozkurt Oflaz A, Karabagli P, Gedik S, Bozkurt B. Eyelid molluscum contagiosum lesions in two patients with unilateral chronic conjunctivitis. Turk J Ophthalmol  2017;47:226–230.
  19. Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacteria  conjunctivitis. Am J Ophthalmol 1991;112:29s–33s.
  20. Hovding G. Acute bacterial conjunctivitis. Acta Ophthalmol 2008;86:5–17
  21. Owen CG, Shah A, Henshaw K, Smeeth L, Sheikh A. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. Br J Gen Pract 2004;54:451–456.
  22. Maziak W, Behrens T, Brasky TM, Duhme H, Rzehak P Weiland SK, et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Munster, Germany. Allergy 2003;58:572–579.

Photo
Aarti S. Baware
Corresponding author

Department of pharmacology, LBYP college of pharmacy, Aurangabad, Maharashtra, India

Photo
D. K. Vir
Co-author

Department of pharmacology, LBYP college of pharmacy, Aurangabad, Maharashtra, India

Photo
Gajanan Sanap
Co-author

Department of pharmacology, LBYP college of pharmacy, Aurangabad, Maharashtra, India

Aarti S. Baware*, D. K. Vir, Gajanan Sanap, Eye Conjunctivitis, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 12,913-919. https://doi.org/10.5281/zenodo.10441475

More related articles
Formulation And Identification Of Herbal Elixir Fo...
Akshada B. Walunj, Prajakta S. Waghmare, Prof. Snehal B. Fand, Pr...
Formulation And Evaluation Of Chewable Tablet Of S...
Karthick . S, Vasanthan. A, Dr.Senthil Kumar K L, ...
Clinical Trial Design In Drug Enhance Safety And E...
Sourabh Patil, Shreyash Koli, Suvarna Deshmukh, Tejas Kapase , Sa...
Formulation And Evaluation Of Tridax Procumbens Emulgel...
Bhapkar Sachin Anandrao , Kshirsagar M.B, Garje S.Y, Sayyed G. A., ...
Formulation And Evaluation Of Polyherbal Wound Healing Ointment Using Chromolaen...
Sainabi P, Meghna, Thashreefa P M, Sheetal Krishna T, Vyshnavy Devy D K, ...
A Comprehensive Review Of Gestational Diabetes Mellitus...
Kaula, Vineetha K, Ramakrishna Shabaraya A, ...
Related Articles
Cilnidipine And Risk Factors For Dementia Associated Parkinsonism – A Case Rep...
Dhanya Dharman, Silpa Siva Prasad, Anfi D. P, Shaiju S Dharan, ...
Water Quality Monitoring In SPMVV By IOT Tools ...
K. Swathi, U. Madhavi, D. Kalyani, P. Sai Pratyusha, ...
Clinical Data Management: A Comprehensive Overview Of Methods And Workflow In Cl...
Akash Bhagwan Aher, Atharv Chagan Gadhe, Prashant Vilas Bhakare, Prof.Shweta Kahar, Prof.Kranti Pakh...
Recent advances in clinical evaluation of antiulcer drug...
Tejaswini S. Kamble, Vishavjeet S. Pisal, Pritam Salokhe, sachin Navale, Nilesh Chougule, ...
Formulation And Identification Of Herbal Elixir For Haemoglobin Enhancer Activit...
Akshada B. Walunj, Prajakta S. Waghmare, Prof. Snehal B. Fand, Priyanka B. Khamkar, ...
More related articles
Formulation And Identification Of Herbal Elixir For Haemoglobin Enhancer Activit...
Akshada B. Walunj, Prajakta S. Waghmare, Prof. Snehal B. Fand, Priyanka B. Khamkar, ...
Clinical Trial Design In Drug Enhance Safety And Efficacy...
Sourabh Patil, Shreyash Koli, Suvarna Deshmukh, Tejas Kapase , Sachin Navale, Nilesh Chougule, ...
Formulation And Identification Of Herbal Elixir For Haemoglobin Enhancer Activit...
Akshada B. Walunj, Prajakta S. Waghmare, Prof. Snehal B. Fand, Priyanka B. Khamkar, ...
Clinical Trial Design In Drug Enhance Safety And Efficacy...
Sourabh Patil, Shreyash Koli, Suvarna Deshmukh, Tejas Kapase , Sachin Navale, Nilesh Chougule, ...